Zdorovʹe Rebenka (Mar 2018)

Drug management of oxidation-reduction state of the body in respiratory tract diseases (part 1)

  • A.E. Abaturov,
  • A.P. Volosovets,
  • T.P. Borysova

DOI
https://doi.org/10.22141/2224-0551.13.2.2018.129558
Journal volume & issue
Vol. 13, no. 2
pp. 232 – 240

Abstract

Read online

The review of the literature presents the classification of antioxidant drugs. Modern data are presented on the inhibitors of NOX activity such as natural, synthetic (non-selective and selective), renin-angiotensin-aldosterone system blo­cking drugs and statins. The effect of statins on the oxidation-reduction status, inflammation and remodeling processes of the bronchial tree in chronic obstructive pulmonary disease is shown.

Keywords